Current trends on cannabidiol delivery systems: where are we and where are we going?

Ízola Morais de Medeiros Ramalho Daniel Torres Pereira Giovanna Brunelly Lima Galvão Danielle Teixeira Freire Lucas Amaral-Machado Éverton do Nascimento Alencar Eryvaldo Socrates Tabosa do Egito

Published in: Expert opinion on drug delivery (2021)

Studies reporting CBD-ADS use for medicinal applications were reviewed and revealed multifaceted systems that can overcome the physicochemical drawbacks of CBD and improve its biological activities. Therefore, researchers concluded that the developed CBD-ADS can be used as an alternative to traditional formulations because they show comparable or superior effectiveness in treatment protocols. Although several criteria remain to be met, our findings emphasize the potential of CBD-ADSs for translational therapeutics, particularly for neurological-disorders.

Keyphrases

randomized controlled trial
systematic review
small molecule
adverse drug
risk assessment
brain injury
human health